Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00955344 · ClinicalTrials.gov registry record · NA

Increasing Primary Care Physician Colorectal Cancer Screening Rates

A NA study, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
134
Enrollment target

NCT00955344: Completed NA study, sponsored by University of Pennsylvania.

NCT00955344 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 134 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00955344, a NA study, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
134 participants
Enrollment target

Study Summary

The purpose of the study is to determine if a Web-based intervention increases physician rates of colorectal cancer recommendation rates in a group of physicians participating in the American Board of Internal Medicine's Maintenance of Certification Program. This study will also compare the content of practice improvement plans submitted by the diplomats in each study arm to determine the components of the plans that are associated with colorectal cancer rates.

Interventions

  • BEHAVIORAL eToolbox
  • BEHAVIORAL no link to eToolbox

Trial Details

FieldValue
Enrollment Target 134 participants
Start Date 2009-09
Est. Completion 2011-11
Phase NA
University of Pennsylvania

1,423 total trials

What the finished NCT00955344 record still lists

NCT00955344 is an interventional study that assigns participants to a tested intervention. The registered 134 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 2 interventions - of which eToolbox is the first listed.

NCT00955344 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00955344 about?

NCT00955344 is a clinical study titled "Increasing Primary Care Physician Colorectal Cancer Screening Rates". The purpose of the study is to determine if a Web-based intervention increases physician rates of colorectal cancer recommendation rates in a group of physicians participating in the American Board of Internal Medicine's Maintenance of Certification Program. This study will also compare the content ...

What is the current status of trial NCT00955344?

This trial is currently completed. It is a NA study. The enrollment target is 134 participants. The study started on 2009-09. Estimated completion is 2011-11.

What interventions are being tested in trial NCT00955344?

The interventions under investigation include: eToolbox (BEHAVIORAL), no link to eToolbox (BEHAVIORAL).

Who is sponsoring clinical trial NCT00955344?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00955344's enrollment target sits among peer trials

134 728th of 2000 higher than 1,272 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02469662 · 134 participants · NA

    Clinical Outcomes Study of the Nexel Total Elbow

  • NCT03110822 · 134 participants · Phase 1

    A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients

  • NCT04678648 · 134 participants · Phase 1

    A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

  • NCT05264857 · 134 participants · NA

    Decision Aid and Thyroid Nodules Management

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00955344, the US trial registry maintained by the National Library of Medicine. NCT00955344 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.